» Articles » PMID: 18178618

ICA512 Signaling Enhances Pancreatic Beta-cell Proliferation by Regulating Cyclins D Through STATs

Overview
Specialty Science
Date 2008 Jan 8
PMID 18178618
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Changes in metabolic demands dynamically regulate the total mass of adult pancreatic beta-cells to adjust insulin secretion and preserve glucose homeostasis. Glucose itself is a major regulator of beta-cell proliferation by inducing insulin secretion and activating beta-cell insulin receptors. Here, we show that islet cell autoantigen 512 (ICA512)/IA-2, an intrinsic tyrosine phosphatase-like protein of the secretory granules, activates a complementary pathway for beta-cell proliferation. On granule exocytosis, the ICA512 cytoplasmic domain is cleaved and the resulting cytosolic fragment (ICA512-CCF) moves into the nucleus where it enhances the levels of phosphorylated STAT5 and STAT3, thereby inducing insulin gene transcription and granule biogenesis. We now show that knockdown of ICA512 decreases cyclin D1 levels and proliferation of insulinoma INS-1 cells, whereas beta-cell regeneration is reduced in partially pancreatectomized ICA512-/- mice. Conversely, overexpression of ICA512-CCF increases both cyclin D1 and D2 levels and INS-1 cell proliferation. Up-regulation of cyclin D1 and D2 by ICA512-CCF is affected by knockdown of STAT3 and STAT5, respectively, whereas it does not require insulin signaling. These results identify ICA512 as a regulator of cyclins D and beta-cell proliferation through STATs and may have implication for diabetes therapy.

Citing Articles

What is known and unknown about the role of neuroendocrine genes and .

Stojilkovic S, Sokanovic S, Constantin S Front Endocrinol (Lausanne). 2025; 16:1531723.

PMID: 39926347 PMC: 11802530. DOI: 10.3389/fendo.2025.1531723.


Protein Tyrosine Phosphatase Receptors N and N2 Control Pituitary Melanotroph Development and POMC Expression.

Constantin S, Sokanovic S, Mochimaru Y, Dams A, Smiljanic K, Previde R Endocrinology. 2024; 165(8).

PMID: 38923438 PMC: 11242453. DOI: 10.1210/endocr/bqae076.


Phogrin Regulates High-Fat Diet-Induced Compensatory Pancreatic β-Cell Growth by Switching Binding Partners.

Kubota C, Torii R, Hosaka M, Takeuchi T, Gomi H, Torii S Nutrients. 2024; 16(1).

PMID: 38201998 PMC: 10780347. DOI: 10.3390/nu16010169.


Insulin granule morphology and crinosome formation in mice lacking the pancreatic β cell-specific phogrin (PTPRN2) gene.

Yasui T, Mashiko M, Obi A, Mori H, Ito-Murata M, Hayakawa H Histochem Cell Biol. 2023; 161(3):223-238.

PMID: 38150052 DOI: 10.1007/s00418-023-02256-8.


Affinity purification of serum-derived anti-IA-2 autoantibodies in type 1 diabetes using a novel MBP-IA-2 fusion protein.

Mendis T, Filipova B, Wang J, Pietropaolo M, Jackson M Biochem Biophys Rep. 2022; 33:101413.

PMID: 36578528 PMC: 9791830. DOI: 10.1016/j.bbrep.2022.101413.


References
1.
Xu G, Stoffers D, Habener J, Bonner-Weir S . Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes. 1999; 48(12):2270-6. DOI: 10.2337/diabetes.48.12.2270. View

2.
Okada T, Liew C, Hu J, Hinault C, Michael M, Krtzfeldt J . Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A. 2007; 104(21):8977-82. PMC: 1885613. DOI: 10.1073/pnas.0608703104. View

3.
Bonner-Weir S . Perspective: Postnatal pancreatic beta cell growth. Endocrinology. 2000; 141(6):1926-9. DOI: 10.1210/endo.141.6.7567. View

4.
Friedrichsen B, Galsgaard E, Nielsen J, Moldrup A . Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5). Mol Endocrinol. 2001; 15(1):136-48. DOI: 10.1210/mend.15.1.0576. View

5.
Nielsen J, Galsgaard E, Moldrup A, Friedrichsen B, Billestrup N, Hansen J . Regulation of beta-cell mass by hormones and growth factors. Diabetes. 2001; 50 Suppl 1:S25-9. DOI: 10.2337/diabetes.50.2007.s25. View